Published in BMC Med Genomics on June 29, 2011
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res (2006) 44.35
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
A census of human cancer genes. Nat Rev Cancer (2004) 36.20
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
Cancer genes and the pathways they control. Nat Med (2004) 24.22
International network of cancer genome projects. Nature (2010) 20.35
Linkage of early-onset familial breast cancer to chromosome 17q21. Science (1990) 16.21
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer Cell (2007) 11.21
The Pezcoller lecture: cancer cell cycles revisited. Cancer Res (2000) 5.08
COSMIC 2005. Br J Cancer (2006) 5.07
Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci Am (2007) 4.66
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev (2010) 3.99
Genetic predisposition to colorectal cancer. Nat Rev Cancer (2004) 3.92
Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta (2002) 3.77
Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. J Clin Oncol (2010) 2.72
Combinatorial patterns of somatic gene mutations in cancer. FASEB J (2008) 2.40
Big science: The cancer genome challenge. Nature (2010) 1.38
Status of PI3K inhibition and biomarker development in cancer therapeutics. Ann Oncol (2009) 1.37
Analysis and computational dissection of molecular signature multiplicity. PLoS Comput Biol (2010) 1.32
Molecular diagnostics of gliomas: the clinical perspective. Acta Neuropathol (2010) 1.08
Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol (2000) 1.07
Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. BMC Cancer (2006) 0.98
Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma. Melanoma Res (2010) 0.96
Genomic landscapes of cancers: prospects for targeted therapies. Pharmacogenomics (2007) 0.87
Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder. Oncol Rep (2010) 0.81
Somatic mutation signatures of cancer. AMIA Annu Symp Proc (2008) 0.77
The tissue microarray data exchange specification: a community-based, open source tool for sharing tissue microarray data. BMC Med Inform Decis Mak (2003) 2.81
Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res (2003) 2.70
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol (2012) 2.00
Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol (2008) 1.74
Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res (2009) 1.53
Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med (2004) 1.40
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol (2008) 1.03
Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS One (2011) 1.02
Predicting phenotypic severity of uncertain gene variants in the RET proto-oncogene. PLoS One (2011) 0.98
Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family. BMC Med Genomics (2009) 0.97
Bagged gene shaving for the robust clustering of high-throughput data. Int J Bioinform Res Appl (2010) 0.95
Menthol induces cell-cycle arrest in PC-3 cells by down-regulating G2/M genes, including polo-like kinase 1. Biochem Biophys Res Commun (2012) 0.85
Using prior knowledge and rule induction methods to discover molecular markers of prognosis in lung cancer. AMIA Annu Symp Proc (2005) 0.83
Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers. BMC Med Genomics (2013) 0.83
Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma. Histopathology (2011) 0.81
Challenges of the information age: the impact of false discovery on pathway identification. BMC Res Notes (2012) 0.75
Is it too soon to start reporting HER2 genetic heterogeneity? Arch Pathol Lab Med (2010) 0.75
Robust meta-analysis shows that glioma transcriptional subtyping complements traditional approaches. Cell Oncol (Dordr) (2014) 0.75